Walgreens launches cell, gene therapies in service expansion

Walgreens launches cell, gene therapies in service expansion

A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Thursday said it will start to work directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader expansion of its specialty … Read more

Biogen (BIIB) earnings Q1 2024

Biogen (BIIB) earnings Q1 2024

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday reported first-quarter profit that topped estimates as the company’s cost-cutting efforts took hold and sales of its closely watched Alzheimer’s drug, Leqembi, came in higher than expected. Biogen and … Read more

3.6 million Medicare patients could get heart health coverage

3.6 million Medicare patients could get heart health coverage

More than 3 million people with Medicare could be eligible for coverage of Wegovy now that the blockbuster weight loss drug is also approved in the U.S. for heart health, according to an analysis released Wednesday by health policy research organization KFF. But some eligible beneficiaries could still face out-of-pocket costs for the highly popular … Read more

Labor Department cracks down on bad retirement savings advice

Labor Department cracks down on bad retirement savings advice

The U.S. Department of Labor headquarters in Washington. Al Drago/Bloomberg via Getty Images The Biden administration issued a final rule on Tuesday that cracks down on the investment advice that advisors, brokers, insurance agents and others give to retirement savers. The U.S. Department of Labor regulation — which follows a rule proposal in October — … Read more

Spotify (SPOT) earnings Q1 2024

Spotify (SPOT) earnings Q1 2024

Daniel Ek, CEO of Swedish music streaming service Spotify, gestures as he makes a speech at a press conference in Tokyo on September 29, 2016. Toru Yamanaka | AFP | Getty Images Spotify reported first quarter earnings on Tuesday, notching record quarterly profit and beating estimates on the top and bottom lines, after a year … Read more

Activist investor Jana has stake in Wolfspeed, urges sale

Activist investor Jana has stake in Wolfspeed, urges sale

Scott Ostfeld, managing partner and portfolio manager with JANA Partners LLC., speaks during the 13D Monitor’s Active-Passive Investor Summit in New York City, U.S., October 17, 2023.  Brendan Mcdermid | Reuters Activist investor Jana Partners has a built a “significant” position in semiconductor firm Wolfspeed and is calling on the company to resolve a “staggering … Read more

Informatica not in acquisition talks with Salesforce

Informatica not in acquisition talks with Salesforce

Amit Walia, CEO, Informatica at the New York Stock Exchange, October 27, 2021. Source: NYSE Enterprise data management company Informatica is not currently in talks to be acquired, the company said on Monday, after earlier reports suggested Salesforce was interested in a roughly $10 billion deal. Informatica shares slumped more than 7% on the news, … Read more

Weight loss drug patients spend less on restaurants, takeout: survey

Weight loss drug patients spend less on restaurants, takeout: survey

A food delivery messenger carries a take out bag outside aSweetgreen in Manhattan on September 14, 2023. Jeenah Moon | The Washington Post | Getty Images A highly popular group of weight loss and diabetes drugs is decreasing some consumers’ appetites — and also how much they spend on food. Most people taking those medications, … Read more

Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says 

Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says 

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.  Brendan McDermid | Reuters Most doses of Eli Lilly‘s highly popular weight loss drug Zepbound and diabetes counterpart Mounjaro will be in short supply through the second quarter of this year as demand jumps, according … Read more

Eli Lilly weight loss drug Zepbound effective in sleep apnea trials

Eli Lilly weight loss drug Zepbound effective in sleep apnea trials

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.  Brendan McDermid | Reuters Eli Lilly on Wednesday said its highly popular weight loss drug Zepbound showed the potential to treat patients with the most common sleep-related breathing disorder in two late-stage clinical trials. The … Read more